Cargando…
Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains
IgM is a multivalent antibody which evolved as a first line defense of adaptive immunity. It consists of heavy and light chains assembled into a complex oligomer. In mouse serum there are two forms of IgM, a full-length and a truncated one. The latter contains μ’ chain, which lacks a variable region...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764968/ https://www.ncbi.nlm.nih.gov/pubmed/29323348 http://dx.doi.org/10.1038/s41598-017-19003-4 |
_version_ | 1783292131960422400 |
---|---|
author | Klaus, Tomasz Stalińska, Krystyna Czaplicki, Dominik Mak, Paweł Skupien-Rabian, Bozena Kedracka-Krok, Sylwia Wiatrowska, Karolina Bzowska, Monika Machula, Monika Bereta, Joanna |
author_facet | Klaus, Tomasz Stalińska, Krystyna Czaplicki, Dominik Mak, Paweł Skupien-Rabian, Bozena Kedracka-Krok, Sylwia Wiatrowska, Karolina Bzowska, Monika Machula, Monika Bereta, Joanna |
author_sort | Klaus, Tomasz |
collection | PubMed |
description | IgM is a multivalent antibody which evolved as a first line defense of adaptive immunity. It consists of heavy and light chains assembled into a complex oligomer. In mouse serum there are two forms of IgM, a full-length and a truncated one. The latter contains μ’ chain, which lacks a variable region. Although μ’ chain was discovered many years ago, its origin has not yet been elucidated. Our results indicate that μ’ chain is generated from a full-length heavy chain by non-enzymatic cleavage of the protein backbone. The cleavage occurred specifically after Asn209 and is prevented by mutating this residue into any other amino acid. The process requires the presence of other proteins, preferentially with an acidic isoelectric point, and is facilitated by neutral or alkaline pH. This unique characteristic of the investigated phenomenon distinguishes it from other, already described, Asn-dependent protein reactions. A single IgM molecule is able to bind up to 12 epitopes via its antigen binding fragments (Fabs). The cleavage at Asn209 generates truncated IgM molecules and free Fabs, resulting in a reduced IgM valence and probably affecting IgM functionality in vivo. |
format | Online Article Text |
id | pubmed-5764968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-57649682018-01-17 Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains Klaus, Tomasz Stalińska, Krystyna Czaplicki, Dominik Mak, Paweł Skupien-Rabian, Bozena Kedracka-Krok, Sylwia Wiatrowska, Karolina Bzowska, Monika Machula, Monika Bereta, Joanna Sci Rep Article IgM is a multivalent antibody which evolved as a first line defense of adaptive immunity. It consists of heavy and light chains assembled into a complex oligomer. In mouse serum there are two forms of IgM, a full-length and a truncated one. The latter contains μ’ chain, which lacks a variable region. Although μ’ chain was discovered many years ago, its origin has not yet been elucidated. Our results indicate that μ’ chain is generated from a full-length heavy chain by non-enzymatic cleavage of the protein backbone. The cleavage occurred specifically after Asn209 and is prevented by mutating this residue into any other amino acid. The process requires the presence of other proteins, preferentially with an acidic isoelectric point, and is facilitated by neutral or alkaline pH. This unique characteristic of the investigated phenomenon distinguishes it from other, already described, Asn-dependent protein reactions. A single IgM molecule is able to bind up to 12 epitopes via its antigen binding fragments (Fabs). The cleavage at Asn209 generates truncated IgM molecules and free Fabs, resulting in a reduced IgM valence and probably affecting IgM functionality in vivo. Nature Publishing Group UK 2018-01-11 /pmc/articles/PMC5764968/ /pubmed/29323348 http://dx.doi.org/10.1038/s41598-017-19003-4 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Klaus, Tomasz Stalińska, Krystyna Czaplicki, Dominik Mak, Paweł Skupien-Rabian, Bozena Kedracka-Krok, Sylwia Wiatrowska, Karolina Bzowska, Monika Machula, Monika Bereta, Joanna Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains |
title | Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains |
title_full | Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains |
title_fullStr | Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains |
title_full_unstemmed | Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains |
title_short | Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains |
title_sort | mouse antibody of igm class is prone to non-enzymatic cleavage between ch1 and ch2 domains |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764968/ https://www.ncbi.nlm.nih.gov/pubmed/29323348 http://dx.doi.org/10.1038/s41598-017-19003-4 |
work_keys_str_mv | AT klaustomasz mouseantibodyofigmclassispronetononenzymaticcleavagebetweench1andch2domains AT stalinskakrystyna mouseantibodyofigmclassispronetononenzymaticcleavagebetweench1andch2domains AT czaplickidominik mouseantibodyofigmclassispronetononenzymaticcleavagebetweench1andch2domains AT makpaweł mouseantibodyofigmclassispronetononenzymaticcleavagebetweench1andch2domains AT skupienrabianbozena mouseantibodyofigmclassispronetononenzymaticcleavagebetweench1andch2domains AT kedrackakroksylwia mouseantibodyofigmclassispronetononenzymaticcleavagebetweench1andch2domains AT wiatrowskakarolina mouseantibodyofigmclassispronetononenzymaticcleavagebetweench1andch2domains AT bzowskamonika mouseantibodyofigmclassispronetononenzymaticcleavagebetweench1andch2domains AT machulamonika mouseantibodyofigmclassispronetononenzymaticcleavagebetweench1andch2domains AT beretajoanna mouseantibodyofigmclassispronetononenzymaticcleavagebetweench1andch2domains |